Details for Patent: 9,132,071

✉ Email this page to a colleague

Which drugs does patent 9,132,071 protect, and when does it expire?

Patent 9,132,071 protects VERKAZIA and is included in one NDA.

This patent has forty-three patent family members in eighteen countries.

Summary for Patent: 9,132,071

Patent landscape, scope, and claims:

Title:	Compositions containing quaternary ammonium compounds
Abstract:	Compositions containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, where composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Ophthalmic oil-in-water emulsions containing such compositions, and the ophthalmic emulsions being are useful for eye care or for the treatment of eye conditions.
Inventor(s):	Rabinovich-Guilatt; Laura (Kadima, IL), Lambert; Gregory (Chatenay Malabry, FR), Lallemand; Frederic (Fresnes, FR), Philips; Betty (Antony, FR)
Assignee:	SANTEN SAS (Evry, FR)
Application Number:	12/010,778
Patent Claim Types: see list of patent claims	Compound;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,132,071

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Harrow Eye	VERKAZIA	cyclosporine	EMULSION;OPHTHALMIC	214965-001	Jun 23, 2021		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,132,071

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	06291236	Jul 28, 2006

International Family Members for US Patent 9,132,071

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2049079	⤷ Subscribe	PA2017003	Lithuania	⤷ Subscribe
European Patent Office	2049079	⤷ Subscribe	LUC00006	Luxembourg	⤷ Subscribe
European Patent Office	2049079	⤷ Subscribe	PA2017003,C2049079	Lithuania	⤷ Subscribe
Australia	2007278141	⤷ Subscribe
Canada	2659322	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.